Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus 0.03% ointment versus triamcinolone acetonide oral ointment for labial lesions of chronic discoid lupus erythematosus or oral lichen planus
ChiCTR-TRC-11001195Phase 4Completed
- Sponsor
- West China Hospital of Stomatology, Sichuan University
- Start
- Jun 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus and triamcinolone acetonide in discoid lupus erythematosus (DLE) and oral lichen planus (OLP) (2 arms), sponsored by West China Hospital of Stomatology, Sichuan University. Primary endpoints: Lesion size and Pain level. Started Jun 2010; status: completed.
02
Drugs
tacrolimustriamcinolone acetonide
03
Conditions
discoid lupus erythematosus (DLE)oral lichen planus (OLP)
Beyond the preview
Go deeper on ChiCTR-TRC-11001195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001195.